These results are consistent with findings in a retrovirally induced MLL-AF9 AML mouse model (Hanoun et al., 2014) and contrast with reduced NESTIN+ niches in human or mouse MPN (Arranz et al., 2014; Drexler et al., 2019). This evidence concerns the gene MLLT3 and myeloproliferative neoplasm.